Pack
30 tablet
100 tablet
1 tablet

Commissioned by specialist commissioning

Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack
Pack
1 pack

Denosumab - For prevention of osteoporotic fractures in postmenopausal women:

  • All new patients should be initiated on a biosimilar product.
  • Biosimilar brands approved for local use: Stoboclo (Celltrion), Jubbonti (Sandoz), Junod (Gedeon Richter)
  • Patients discharged from hospital after being started on a different denosumab biosimilar (such as Zadenvi® locally) or the originator product Prolia® should be switched to the locally preferred products in line with agreed guidance.

Denosumab Patient Information Leaflet 

Pack
1 pre-filled disposable injection
Pack
1 pre-filled disposable injection
Pack
1 pre-filled disposable injection
Pack
1 pre-filled disposable injection